Voyager Therapeutics (VYGR) Asset Utilization Ratio (2015 - 2026)

Voyager Therapeutics has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.16 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.16, down 13.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.16 (down 13.67% YoY), and the FY2025 annual result was 0.13, down 41.79% from the prior year.
• Asset Utilization Ratio came in at 0.16 for Q1 2026 at Voyager Therapeutics, up from 0.15 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q4 2023 to a low of 0.1 in Q3 2025.
• The 5-year median for Asset Utilization Ratio is 0.24 (2022), against an average of 0.32.
• Across the five-year window, Asset Utilization Ratio plunged 76.37% in 2022 and jumped 409.54% in 2023, its largest moves.
• Voyager Therapeutics' Asset Utilization Ratio stood at 0.24 in 2022, then soared by 223.55% to 0.77 in 2023, then plunged by 74.76% to 0.2 in 2024, then decreased by 23.37% to 0.15 in 2025, then climbed by 3.56% to 0.16 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.16 (Q1 2026), 0.15 (Q4 2025), and 0.1 (Q3 2025), per Business Quant data.